《亞洲市況》日經平均指數全日跌2.8% 索尼重挫近13%
日本股市午後跌幅擴大,日經平均指數尾市曾跌942點見27,314點,收市跌790.02點或2.8%,報27,467.23點。美債孳息上升引發股市下跌,油價上升亦引發市場憂慮日企業績,對大市構成沽壓。
美着名遊戲商暴視動雪獲科技巨擘微軟提購,競爭對手索尼股價挫12.8%,成交額逾1,900億日圓,爲日本交易所全日成交最活躍股份。
晶片相關股受挫,晶片檢測器生產商Lasertec及晶片成模器生產商東京威力科創各跌7.1%及6.1%。航運股重挫,川崎汽船、日本郵船及商船三井各跌10.3%、9.3%及8.1%。汽車股豐田亦跌5%。
日圓午後繼續上揚,美元兌日圓最新報114.28。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.